Phase II escalation study of sorafenib in patients with advanced renal cell carcinoma who progressed after routine dosage of sorafenib

Update Il y a 4 ans
Reference: ChiCTR-ONRC-12002088

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Renal Cell Carcinoma

Links